JNJ
Johnson & Johnson
Cash flow statement
| USDLine, in USD | Last 12 months | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 26.2B | 24.5B | 24.3B | 22.8B | 21.2B | 23.4B | 23.5B | 23.4B | 22.2B | 21.1B | 18.8B | 19.6B | 18.7B | 17.4B | 15.4B | 14.3B | 16.4B | 16.6B | 15.0B | 15.0B |
| 5.57B | 4.83B | 4.42B | 4.54B | 4.01B | 3.65B | 3.35B | 3.50B | 3.67B | 3.28B | 3.23B | 3.46B | 3.71B | 3.60B | 2.93B | 2.89B | 2.38B | 2.37B | 3.07B | 2.94B | |
| Free cash flow | 20.6B | 19.7B | 19.8B | 18.2B | 17.2B | 19.8B | 20.2B | 19.9B | 18.5B | 17.8B | 15.5B | 16.1B | 15.0B | 13.8B | 12.5B | 11.4B | 14.0B | 14.2B | 11.9B | 12.1B |
| Depreciation and amortization | 8.09B | 7.50B | 7.34B | 7.49B | 6.97B | 7.39B | 7.23B | 7.01B | 6.93B | 5.64B | 3.75B | 3.75B | 3.90B | 4.10B | 3.67B | 3.16B | 2.94B | 2.77B | 2.83B | 2.78B |
| Stock-based compensation | 1.42B | 1.35B | 1.18B | 1.16B | 1.14B | 1.14B | 1.01B | 0.98B | 0.98B | 0.96B | 0.88B | 0.87B | 0.79B | 0.73B | 0.66B | 0.62B | 0.61B | 0.63B | 0.63B | 0.70B |
| Buybacks | 7.9B | 6.0B | 2.4B | 5.1B | 6.0B | 3.5B | 3.2B | 6.7B | 5.9B | 6.4B | 9.0B | 5.3B | 7.1B | 3.5B | 12.9B | 2.5B | 2.8B | 2.1B | 6.7B | 5.6B |
| Dividends per share | 5.28 | 5.14 | 4.91 | 4.70 | 4.45 | 4.19 | 3.98 | 3.75 | 3.54 | 3.32 | 3.15 | 2.95 | 2.76 | 2.59 | 2.40 | 2.25 | 2.11 | 1.93 | 1.80 | 1.62 |
| Free cash flow margin | 20.7% | 20.9% | 22.3% | 21.4% | 21.5% | 25.1% | 24.4% | 24.3% | 22.7% | 23.3% | 21.6% | — | — | — | — | — | — | — | — | — |